PureTech Health plc EBIT

As of the most recent data (December 2025), PTCHF shows a EBIT of $-65M. That compares with $-220M in the prior-year period — up 70.5% year over year. That is below the Finance sector average of $340B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PTCHF's EBIT is now $-65M (was $-220M) — a 70.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether PureTech Health plc is outperforming or lagging.

The Finance sector average EBIT is about $340B. PureTech Health plc is at $-65M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how PTCHF stacks up against individual peers as well.

Tracking PTCHF's ebit over time shows whether PureTech Health plc is scaling, shrinking, or reshaping that part of the business. The current reading is $-65M That compares with $-220M in the prior-year period — up 70.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has PureTech Health plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-65M) with ownership activity and broader fundamentals.